Covetrus, Inc. (CVET)
| Market Cap | 3.98B |
| Revenue (ttm) | 4.34B |
| Net Income (ttm) | -19.00M |
| Shares Out | 118.00M |
| EPS (ttm) | -0.22 |
| PE Ratio | n/a |
| Forward PE | 31.45 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 16 |
| Last Price | $29.21 |
| Previous Close | $29.79 |
| Change ($) | -0.58 |
| Change (%) | -1.95% |
| Day's Open | 30.11 |
| Day's Range | 28.77 - 30.20 |
| Day's Volume | 500,566 |
| 52-Week Range | 7.51 - 40.77 |
PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus announced the addition of Stacey M.M. Shirra as vice president of global talent management.
Covetrus (CVET) delivered earnings and revenue surprises of 25.00% and 5.88%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus reported financial results for the fourth quarter and full-year 2020, which ended December 31, 2020.
PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #animalhealth--Covetrus appoints Link Welborn, DVM, DABVP as Covetrus' chief veterinary officer (CVO) in North America.
PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus will release fourth quarter and full-year 2020 results the morning of Monday, March 1, 2021.
PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus announced the appointment of its first-ever chief consumer officer.
LONDON & PORTLAND, Maine--(BUSINESS WIRE)--Covetrus received top recognition from the Learning Technologies Awards for its project with Dogs Trust, the largest dog welfare charity in the UK.
Covetrus, Inc. presents as a value proposition on a backdrop of incremental growth and successful acquisition integrations. Success in the high margin prescription management segment acts as a key growt...
PORTLAND, Maine--(BUSINESS WIRE)-- #animalhealth--Animal-health technology and services company, Covetrus, to participate in the 39th Annual J.P. Morgan Healthcare Conference.
Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.
Covetrus (CVET) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Finding cheap stocks isn't just about price -- it's about finding great companies that are trading at a discout to their actual worth. The post 5 Cheap Stocks With Great-Performing Companies appeared fi...
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus completes separation from former parent company ahead of schedule enabling the Company to deliver greater coordination of its businesses.
Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.
Covetrus' (CVET) CEO Ben Wolin on Q3 2020 Results - Earnings Call Transcript
Covetrus (CVET) delivered earnings and revenue surprises of 43.75% and 8.17%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 52.94% year over year to $0.26, which beat the esti...
PORTLAND, Maine, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Covetrus, Inc. (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the third quarter of 202...
CVET vs. CRWD: Which Stock Is the Better Value Option?
Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results afte...
Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.
CVET vs. CRWD: Which Stock Is the Better Value Option?
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus made a strategic investment in VSG, the leading provider of peer-to-peer learning experiences for veterinary practice leaders.
Covetrus, Inc. (NASDAQ : CVET; $22.98; Market Capitalization: $2.6 billion) is on a path of fast-tracked recovery as the company has managed to successfully reboot its operations in the U. S., where COV...
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announced the agenda and speaker lineup for its annual VetSummit conference that is to take place October 16-18.
Despite the economic challenges of the pandemic, Americans are spoiling their pets. Profit from that hot market with these top growth stocks.
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus, a global leader in animal-health technology & services, announces appointment of Jamey Seely as general counsel effective Sept. 1, 2020.
PHOENIX--(BUSINESS WIRE)--Covetrus donated 6,000 bottles of hand sanitizer to help protect Phoenix communities and Arizona medical personnel from coronavirus.
CVET vs. SOGO: Which Stock Is the Better Value Option?
Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.
Covetrus Inc. (CVET) CEO Ben Wolin on Q2 2020 Results - Earnings Call Transcript
Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q2 results.
Covetrus (CVET) delivered earnings and revenue surprises of 137.50% and 13.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
PORTLAND, Maine, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Covetrus (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the second quarter of 2020, ...
Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PORTLAND, Maine, July 28, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2020 results...
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announces promotion of Ditte Marstrand Wulf to global chief human resources officer.
PORTLAND, Maine, June 25, 2020 (GLOBE NEWSWIRE) -- Covetrus ™ (NASDAQ: CVET), a global leader in animal-health technology and services, announced today its board of directors has declared a quarterly...
With these three animal-health stocks, your portfolio will be stronger than ever.
As of late, it has definitely been a great time to be an investor in Covetrus.
Covetrus Inc. (CVET) CEO Ben Wolin on Q1 2020 Results - Earnings Call Transcript
Covetrus (CVET) delivered earnings and revenue surprises of -5.56% and -0.27%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Covetrus (CVET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
About CVET
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that in... [Read more...]
| Industry Health Information Services | |
| Stock Exchange NASDAQ | Ticker Symbol CVET |
Financial Performance
In 2020, Covetrus's revenue was $4.34 billion, an increase of 9.13% compared to the previous year's $3.98 billion. Losses were -$19.00 million, -98.06% less than in 2019.
Analyst Forecasts
According to 7 analysts, the average rating for Covetrus stock is "Buy." The 12-month stock price forecast is 34.20, which is an increase of 17.08% from the latest price.